Company intelligence / Profile preview

Progen Diagnostics

Heidelberg, Baden-Württemberg, Germany

Ownership: Private
Development stage: Commercial

Overview

PROGEN is a leading manufacturer of antibodies, recombinant proteins, ELISA kits, and specialized analytical tools for adeno-associated virus (AAV) gene therapy research. Their products are widely published and validated in international studies. The company is ISO 13485 certified and has been recognized for innovation in life science reagents since its founding in 1983.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: AntibodyRecombinant proteinELISA kitDensity gradient mediaAAV gene therapy tools
Industry: Protein Biomarker Diagnostics

Partnerships

Academic collaborations worldwide; strong network with academic institutions and industry partners since 1983.Part of the R-Biopharm Group partnership network.

Beyond the preview

Go deeper on Progen Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progen Diagnostics.

Explore the full profile